Quest for the right Drug

|

אדויל לילדים בטעם פירות CHILDREN'S ADVIL FRUIT FLAVOR (IBUPROFEN)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

פומי : PER OS

צורת מינון:

תרחיף : SUSPENSION

Interactions : אינטראקציות

4.5 Interaction with other medicinal products and other forms of interaction
Ibuprofen should be avoided in combination with:
• Acetylsalicylic acid (aspirin): Unless low-dose acetylsalicylic acid (aspirin) (not above 75mg daily) has been advised by a doctor, as this may increase the risk of adverse reactions (See section 4.4).

Experimental data suggest that ibuprofen may inhibit the effect of low dose acetylsalicylic acid (aspirin) on platelet aggregation when they are dosed concomitantly. However, the limitations of these data and the uncertainties regarding extrapolation of ex vivo data to the clinical situation imply that no firm conclusions can be made for regular ibuprofen use, and no clinically relevant effect is considered to be likely for occasional ibuprofen use (see section 5.1).

•   Other NSAIDs including cyclooxygenase-2 selective inhibitors: Avoid concomitant use of two or more NSAIDs as this may increase the risk of adverse effects (see section 4.4)

Ibuprofen should be used with caution in combination with:
Anticoagulants: NSAIDS may enhance the effects of anti-coagulants, such as warfarin (See section 4.4).

Antihypertensives (ACE inhibitors and Angiotensin II antagonists) and diuretics: NSAIDs may diminish the effect of these drugs. Diuretics can increase the risk of nephrotoxicity of NSAIDs.

Corticosteroids: Increased the risk of gastrointestinal ulceration or bleeding (see Section 4.4)

Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): increased risk of gastrointestinal bleeding (see section 4.4).

Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR and increase plasma glycoside levels.

Lithium: There is evidence for potential increases in plasma levels of lithium.

Methotrexate: There is a potential for an increase in plasma levels of methotrexate.
Ciclosporin: Increased risk of nephrotoxicity.
Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration as NSAIDs can reduce the effect of mifepristone.

Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are given with tacrolimus

Zidovudine: Increased risk of haematological toxicity when NSAIDs are given with zidovudine. There is evidence of an increased risk haemarthroses and haematoma in HIV (positive) haemophiliacs receiving concurrent treatment with zidovudine and ibuprofen.

Quinolone antibiotics: Animal data indicate that NSAIDs can increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions

שימוש לפי פנקס קופ''ח כללית 1994 Rheumatoid arthritis & osteoarthritis, mild to moderate pain, dysmenorrhea
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה שאושרה לשימוש כללי בקופ'ח

בעל רישום

HALEON CH ISRAEL LTD.

רישום

122 42 30110 00

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

15.12.21 - עלון לרופא

עלון מידע לצרכן

15.03.22 - עלון לצרכן אנגלית 15.03.22 - עלון לצרכן עברית 15.03.22 - עלון לצרכן ערבית 27.02.23 - עלון לצרכן עברית 29.09.24 - עלון לצרכן עברית 09.12.20 - החמרה לעלון 15.12.21 - החמרה לעלון 27.02.23 - החמרה לעלון

לתרופה במאגר משרד הבריאות

אדויל לילדים בטעם פירות

קישורים נוספים

RxList WebMD Drugs.com